2025 Europe Autoimmune Disease Diagnosis Market Revenue Opportunities Report
Description
The 2025 Europe Autoimmune Disease Diagnosis Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Autoimmune Disease Diagnosis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the autoimmune disease diagnosis market in Europe are Abbott Laboratories, bioMérieux Inc., Bio-Rad Laboratories, and Thermo Fisher Scientific Inc. Abbott Laboratories offers a diverse portfolio of diagnostic solutions tailored for autoimmune diseases, contributing significantly to early detection and monitoring. BioMérieux provides advanced diagnostics focusing on immunological assays, enhancing clinical outcomes across autoimmune conditions. Bio-Rad Laboratories is known for its innovative multiplex assays and reagents that streamline autoimmune testing workflows. Thermo Fisher Scientific recently launched the Phadia 2500+ series, expanding automated capabilities for diagnosing a broad range of autoimmune disorders.
These companies leverage advanced immunoassay technologies such as ELISA, immunofluorescence, and multiplex immunoassays to address diseases including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. Siemens Healthineers AG also remains a key player in Europe with significant contributions through biomarker panels and diagnostic platforms. The European autoimmune diagnostics market benefits from collaborations and innovations driven by these leaders, facilitating better disease management across key regions such as Germany, France, and the UK. Rising market demand is fuelled by increased screening initiatives, healthcare investments, and technological advancements supporting multiplexed, efficient, and automation-friendly diagnostics.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Autoimmune Disease Diagnosis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the autoimmune disease diagnosis market in Europe are Abbott Laboratories, bioMérieux Inc., Bio-Rad Laboratories, and Thermo Fisher Scientific Inc. Abbott Laboratories offers a diverse portfolio of diagnostic solutions tailored for autoimmune diseases, contributing significantly to early detection and monitoring. BioMérieux provides advanced diagnostics focusing on immunological assays, enhancing clinical outcomes across autoimmune conditions. Bio-Rad Laboratories is known for its innovative multiplex assays and reagents that streamline autoimmune testing workflows. Thermo Fisher Scientific recently launched the Phadia 2500+ series, expanding automated capabilities for diagnosing a broad range of autoimmune disorders.
These companies leverage advanced immunoassay technologies such as ELISA, immunofluorescence, and multiplex immunoassays to address diseases including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. Siemens Healthineers AG also remains a key player in Europe with significant contributions through biomarker panels and diagnostic platforms. The European autoimmune diagnostics market benefits from collaborations and innovations driven by these leaders, facilitating better disease management across key regions such as Germany, France, and the UK. Rising market demand is fuelled by increased screening initiatives, healthcare investments, and technological advancements supporting multiplexed, efficient, and automation-friendly diagnostics.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
